MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
- Conditions
- Non ST Segment Elevation Acute Coronary Syndrome
- Registration Number
- NCT06197724
- Lead Sponsor
- Qilu Hospital of Shandong University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> 1. Age 18 years or older;<br><br> 2. Patients with symptoms of myocardial ischemia such as angina who are suspected to<br> NSTE-ACS and proposed to undergo CAG or coronary CTA;<br><br> 3. Signed informed consent.<br><br>Exclusion Criteria:<br><br> 1. Patients with ST-elevation myocardial infarction (STEMI);<br><br> 2. Patients with Non-ischemic dilated cardiomyopathy, or hypertrophic cardiomyopathy,<br> or moderate or severe valvular disease;<br><br> 3. Patients with Hemodynamic instability (systolic blood pressure<90 mmHg, or who<br> requires vasoactive drugs), or patients with tachyarrhythmia, ? degree<br> atrioventricular block and above that have not returned to normal;<br><br> 4. Patients who have severe renal abnormality with eGFR <30 ml/min, or patients who are<br> on dialysis;<br><br> 5. Patients with malignant tumors with predicted survival of less than 1 year;<br><br> 6. Pregnant or breastfeeding women;<br><br> 7. Patients who are unable to enter the MCG device, who are unable to perform MCG<br> examination due to interference from metal implants or other reasons, or who are<br> deemed by the investigators to be unsuitable for enrollment.
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of MCG to detect coronary ischemia in patients with suspected NSTE-ACS
- Secondary Outcome Measures
Name Time Method Efficacy of MCG in identifying coronary ischemia in patients with normal ECG.;The time saved by using MCG in the detection of NSTEMI compared to troponin;Efficacy of MCG in evaluating the severity of coronary lesions.;Efficacy of MCG in early stratification of patients with suspected NSTE-ACS